Equity
€159,898 ▲ 127%
Equity rose in 2025 from €70,594 to €159,898.
AGevers
Overview
Lifetime
2 annual accounts with figures on one time axispeak €118,584 (2025)
€118,584▲ 56.8%
peak €89,305 (2025)
€89,305▲ 47.4%
peak €159,898 (2025)
€159,898▲ 127%
€68,248▲ 191%
Board1 name since 2024
1 director
Documentsfilings and deeds
29-09-202660 days late
2025micro format
Gross margin from €75,604 to €118,584Result from €60,594 to €89,305Equity from €70,594 to €159,898Debts from €23,433 to €68,248Cash from €44,990 to €94,237
Key points
from the 2025 annual accountsTurnover
≈ €300,000 estimated
The micro format states no turnover.
Investments
€68,237 12.7 × depreciation
Green is investment, beige is depreciation.
2025 accounts filed 60 days after the deadline
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,326 companies had the same profile as AGevers has now. Each dot stands for 99 companies, two years later.
95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,326 companies, not a prediction for AGevers. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered office moved to Wezembeek-Oppem
New registered office: Berkenhof 28, 1970 Wezembeek-Oppem · Previous registered office: Watermaal-Bosvoorde · General meeting of 30-01-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1015108166
Incorporation
Founding capital of €10,000, 100 shares · Founder: · Appointment: (sole director) · published on 17-10-2024 · Gazette deed
First establishment
Ijsvogellaan 54, Watermael-Boitsfort
Official details
Source: KBO- Status
- Active since 15-10-2024Normal situation
- Activity
- “De uitoefening van de geneeskunde” (deed in Dutch)From the articlesNo NACE code in the KBO yet
- Establishment unit
- 2.370.251.3191170 Watermael-Boitsfort, since 15-10-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 21-11-2025
Annual accounts 2025
- €118,584▲ 56.8%
- €89,305▲ 47.4%
- €159,898▲ 127%
- €228,146▲ 143%
- Filing
- Filed on 29-09-2026
Insights on AGevers
AGevers has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €159,898 and a net result of €89,305.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 29-09-2026, 60 days late€118,584
▲ 56.8%
€112,797
▲ 49.2%
€89,305
▲ 47.4%
€113,194
▲ 57.5%
70.1%
▼ 5.0 percentage points
3.17
▼ 1.07
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €300,000. Estimated: probably between €200,000 and €460,000.
Balance sheet
balance sheet total €228,146 on 31-12-2025What the company ownsHow it is paid for
in euro
in euro
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| Balance sheet: assets | |||
20/58 |
228,146 | 94,027 | |
21/28 |
62,883 | - | |
22/27 |
62,883 | - | |
24 |
51,798 | - | |
26 |
11,085 | - | |
29/58 |
165,263 | 94,027 | |
54/58 |
94,237 | 44,990 | |
490/1 |
71,026 | 49,037 | |
| Balance sheet: equity and liabilities | |||
10/49 |
228,146 | 94,027 | |
10/15 |
159,898 | 70,594 | |
10/11 |
10,000 | 10,000 | |
14 |
149,898 | 60,594 | |
17/49 |
68,248 | 23,433 | |
17 |
14,163 | - | |
170/4 |
14,163 | - | |
42/48 |
52,069 | 22,144 | |
42 |
8,168 | - | |
44 |
2,556 | 1,916 | |
440/4 |
2,556 | 1,916 | |
45 |
38,119 | 15,000 | |
450/3 |
38,119 | 15,000 | |
47/48 |
3,226 | 5,229 | |
492/3 |
2,016 | 1,289 | |
| Income statement | |||
9900 |
118,584 | 75,604 | |
630 |
5,354 | - | |
640/8 |
433 | - | |
9901 |
112,797 | 75,604 | |
65/66B |
374 | 11 | |
65 |
374 | 11 | |
9903 |
112,423 | 75,594 | |
67/77 |
23,119 | 15,000 | |
9904 |
89,305 | 60,594 | |
9905 |
89,305 | 60,594 | |
| Appropriation of the result | |||
9906 |
149,898 | 60,594 | |
14P |
60,594 | - | |
| Document | |||
The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 29-09-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank2025 annual accounts filed 60 days after the deadline. Filed on 29 September 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00530798.
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| 118,151 | - | ||
| 94,658 | - | ||
| 68,237 | - | ||
| 49,247 | - | ||
| 113,194 | 71,883 | ||
| 70.1% | 75.1% | ||
| 3.17 | 4.25 | ||
| 0.43 | 0.33 | ||
| 55.9% | 85.8% | ||
| 39.1% | 64.4% | ||
| over 100 | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 |
|---|---|---|
| Tangible fixed assets | €68,237 | - |
| €5,354 | - |
Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)
Insights on AGevers
The operating result for 2025 is 49% higher than in 2024.
Debt's share of the balance-sheet total rises from 24.9% to 29.9%. Equity and debt are higher.
Board & ownership
Board
1 director, since incorporationSole director
current term since 15-10-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 29-09-2026
Mandates through the years
1 name, the dashed line is todaySole director
Board
Mandates as a list
-
- Sole director, appointed by deed of 17-10-2024, still in office
Control
Founder
This company
AGevers
Equity €159,898
Profit €89,305 in 2025
Capital
- Contribution
- €10,000
- Shares
- 100
- Contribution per share
- €100
- Equity per share
- €1,599 in 2025
- Source
- deed of 17-10-2024
Articles of association
- Name, seat, purpose and duration
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 12-02-2026 (in Dutch)
- Capital, shares and profit
- Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
- “Op naam, aandeelhouders mogen kennis nemen van dit register betreffende hun effecten”deed of 12-02-2026 (in Dutch)
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Erfgenamen en legatarissen die geen aandeelhouder van rechtswege worden, zijn ertoe gehouden de toestemming van de medeaandeelhouders te…”deed of 12-02-2026 (in Dutch)
- Share issue ruleThe articles set how and by whom new shares are issued.
- “Onverminderd de naleving van de regels van de Code van medische deontologie en de voorschriften van de Orde der artsen met betrekking tot de…”deed of 12-02-2026 (in Dutch)
- General meeting and financial year
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Friday of May at 18:00deed of 12-02-2026 (in Dutch)
- Audit, dissolution and liquidation
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditordeed of 17-10-2024 (in French)
- Dissolution ruleThe articles set when and by whom the company can be dissolved.
- “De vennootschap kan op elk moment worden ontbonden door beslissing van de algemene vergadering beslissende in de vormen vereist voor de…”deed of 12-02-2026 (in Dutch)
Shareholders
At incorporation
deed of 17-10-2024 ↗
- 100 shares (100%) · €10,000 in cash
Capital transactions
Capital over time
- 12-02-2026 Capital stated in the deed · 100 shares
- 17-10-2024 Incorporation · €10,000 · 100 shares
- 17-10-2024 Converted to unavailable equity · €10,000
Network & group
No group
AGevers has no parent and no holdings in its annual accounts. is the only director. AGevers shares no director with another company.
At the same address
Berkenhof 28, 1970 Wezembeek-Oppem · 1 other company| Louppe, Elisabeth (sole trader)
establishment since 26-02-2026 |
founded in 2026 0546.945.683 |
Timeline
Timeline
7 events since 2024Filings
Financial
Establishments
Address
202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 60 days late
Registered office moved to Wezembeek-OppemNew registered office: Berkenhof 28, 1970 Wezembeek-Oppem · Previous registered office: Watermaal-Bosvoorde · General meeting of 30-01-20264 points ▸
- General meeting, 30-01-2026
- Registered-office move, Berkenhof 28, 1970 Wezembeek-Oppem
- 100 shares
- Power of attorney,
- The deed holds 3 more points.
2025
Equity above €150,000 equity €159,898 ▲127% With a profit in every financial year since 2024, equity grows to €159,898.
Registered in the Peppol Directory Reachable for e-invoices through 0208:1015108166
Annual accounts 2024 filed NBBmicro format · 28 days late
2024
IncorporationFounding capital of €10,000, 100 shares · Founder: · Appointment: (sole director) · published on 17-10-20245 points ▸
- Founder,
- Founding capital, €10,000, 100 shares
- Registered office clause, Avenue du Martin-Pêcheur, 54/11, 1170 Watermael-Boitsfort
- Director appointment, (sole director)
- Power of attorney,
- The deed holds 7 more points.
First establishment Ijsvogellaan 54, Watermael-Boitsfort
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Identity
- Enterprise number
- 1015.108.166
- VAT number
- BE 1015.108.166
- Peppol ID
- 0208:1015108166
- Other Peppol ID
- 9925:BE1015108166
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 15-10-2024
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Friday of May at 18:00deed of 12-02-2026 (in Dutch)
- Meeting accessThe articles set who may attend the meeting and what is needed to be admitted.
- “Indien enkel de stemrechten geschorst zijn, mag hij nog steeds deelnemen aan de algemene vergadering zonder te kunnen deelnemen aan de…”deed of 12-02-2026 (in Dutch)
- Adjournment ruleBy law the board may postpone a meeting once, by three weeks.
- “Tenzij de algemene vergadering er anders over beslist, doet deze vergadering geen afbreuk aan de andere genomen besluiten”deed of 12-02-2026 (in Dutch)
- Voting ruleThe articles set which majority the meeting decides by, for example a simple or a special majority.
- “Elke aandeelhouder kan aan ieder andere persoon, al dan niet aandeelhouder, door alle middelen van overdracht, een schriftelijke volmacht…”deed of 12-02-2026 (in Dutch)
- Peppol
- Reachable since 21-11-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- AGevers in Dutch
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 12-02-2026 (in Dutch)
- Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- “Vlaams Gewest”deed of 12-02-2026 (in Dutch)
- Elected domicileThe directors or the company receive official documents at this address.
- “Voor de uitvoering van deze statuten, kiest elke in het buitenland wonende aandeelhouder, bestuurder, commissaris, vereffenaar of…”deed of 12-02-2026 (in Dutch)
Activities
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “De uitoefening van de geneeskunde”deed of 12-02-2026 (in Dutch)
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Berkenhof 28 registered office 1970 Wezembeek-Oppem | ||
| Ijsvogellaan 54 1170 Watermael-Boitsfort 86220 Specialist medical practice | 15-10-2024 | 2.370.251.319 |
Buildings and parcels at the addresses
- Ground area
- 5,752 m²
- Buildings
- 1,146 m²
- Volume, LiDAR
- 28,541 m³
- Tallest building
- 29.5 m
Buildings to scale, each on its own parcel
Parcels
Flanders
1
(50%)
Brussels
1
(50%)
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 21017D0012/00K000 | Brussels | 5,077 m² | 1 · 1,060 m² | 29.5 m · 9 |
| 22006B0164/00A003 | Flanders | 675 m² | 1 · 86 m² | 8.8 m · 2 |